"An estimated 20% of travelers say that they have had casual sex with a new partner while in a foreign country. The excitement of being on vacation may encourage people to do things they would not do at home, and the inhibition-lowering effects of"...
TROBICIN Sterile Powder is rapidly absorbed after intramuscular injection. A single, two-gram injection produces peak serum concentrations averaging about 100 mcg/mL at one hour; a single, four-gram injection produces peak serum concentrations averaging 160 mcg/mL at two hours. Average serum concentrations of 15 mcg/mL for the two-gram dose and 31 mcg/mL for the four-gram dose were present eight hours after dosing.
Spectinomycin hydrochloride is an inhibitor of protein synthesis in the bacterial cell; the site of action is the 30S ribosomal subunit.
The in vitro susceptibility of Neisseria gonorrhoeae to spectinomycin hydrochloride can be tested by dilution and diffusion techniques.
Quantitative methods are used to determine antimicrobial minimum inhibitory concentrations (MICs). These MICs provide estimates of the susceptibility of bacteria to antimicrobial compounds. The MICs should be determined using a standardized procedure. Standardized procedures are based on dilution method1,2 (broth, agar, or microdilution) or equivalent using standardized inoculum and concentrations of spectinomycin. The MIC values should be interpreted according to the criteria in Table 1.
Quantitative methods that require measurement of zone diameters also provide reproducible estimates of the susceptibility of bacteria to antimicrobial compounds. One such standardized procedure2,3 requires the use of standardized inoculum concentrations. This procedure uses paper disks impregnated with 100 µg of spectinomycin to test the susceptibility of N. gonorrhoeae to spectinomycin. Interpretation involves correlation of the diameter obtained in the disk test with the MIC for spectinomycin. Reports from the laboratory providing results of the standard single-disk susceptibility test with a 100 µg spectinomycin disk should be interpreted according to the following criteria in Table 1.
Table 1: Interpretive Criteria for Spectinomycin vs. Neisseria
|Disk diffusion (zone diameter mm)|
|*The clinical effectiveness of spectinomycin for treating organisms that produce intermediate results is unknown.|
Standardized susceptibility test procedures require the use of laboratory control microorganisms to monitor and ensure the accuracy and precision of the supplies and reagents used in the assay, and the techniques of the individuals performing the test. Standard spectinomycin powder should provide MIC values as given below. For the diffusion technique, the 100 jag spectinomycin disk should provide the following zone diameters with the quality control strains:
Table 2: In Vitro Susceptibility Test Quality Control
Ranges for Spectinomycin
|Organism|| MIC range
|Disk Diffusion range (mm)|
| N. gonorrhoeae
|ATCC = American Type Culture Collection|
1. Clinical and Laboratory Standards Institute. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically; Approved Standard - 8th ed. CLSI document M07-A8. (ISBN 1-56238-689-1). CLSI, 940 West Valley Road, Suite 1400, Wayne, PA, 19087-1898 USA. 2009.
2. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing; 21st Informational Supplement. CLSI document M100-S21. (ISBN 1-56238-742-1). CLSI, 940 West Valley Road, Suite 1400, Wayne, PA, 19087-1898 USA. 2011
3. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Disk Susceptibility Tests; Approved Standard - 10fh ed. CLSI document M02-A10. (ISBN 1-56238-688-3). CLSI, 940 West Valley Road, Suite 1400, Wayne, PA, 19087-1898 USA. 2009.
Last reviewed on RxList: 3/7/2017
This monograph has been modified to include the generic and brand name in many instances.
Additional Trobicin Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.